INOVIO's $75M Offering: A Tough Medicine for Investors
A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...
Continue Reading